|875 Third Avenue , New York, NY 10022|
|Fund Manager||Sebastian Werner|
|Manager Tenure||3 Years 9 Months|
The fund seeks growth of capital. Main investments. Under normal circumstances, the fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in common stocks of science and technology companies. Science and technology companies are (i) companies whose products, processes, or services, in the opinion of portfolio management, benefit, or are expected to benefit, from the use or commercial application of scientific or technological developments or discoveries; or (ii) companies that, in the opinion of portfolio management, utilize technology and/or science to significantly enhance their business opportunities. Such companies may include companies that, in the opinion of portfolio management, derive a competitive advantage by the application of scientific or technological developments or discoveries. For illustrative purposes, examples of the types of companies in which the fund expects to typically invest include software or hardware manufacturers that invest in developing and maintaining technology products or service offerings; service companies that provide technology service offerings; and biotech companies that invest in scientific research to develop treatments for diseases. The fund may invest in companies of any size and may invest in initial public offerings. While the fund invests mainly in US stocks, it could invest up to 35% of net assets in foreign securities (including emerging markets securities). The fund will concentrate its assets in the group of industries constituting the technology sector and may concentrate in one or more industries in the technology sector. Portfolio management may favor securities from various industries and companies within the technology sector at different times. The fund may also invest up to 20% of its total assets in debt securities, including bonds of private issuers. Management process. In choosing securities, portfolio management uses a combination of three analytical disciplines: Bottom-up research. Portfolio management looks for individual companies that it believes have a history of above-average growth, strong competitive positioning, attractive prices relative to potential growth, innovative products and services, sound financial strength and effective management, among other factors. Growth orientation. Portfolio management generally looks for companies that it believes have above-average potential for sustainable growth of revenue or earnings and whose market value appears reasonable in light of their business prospects. Top-down analysis. Portfolio management considers the economic outlooks for various industries within the technology sector and looks for those that they believe may benefit from changes in the overall business environment. In addition, portfolio management uses quantitative analytic tools to attempt to manage the price volatility of the fund as compared to appropriate benchmarks and peer groups. Portfolio management will normally sell a stock when they believe its price is unlikely to go higher, its fundamentals have changed, other investments offer better opportunities, or in adjusting their emphasis on a given technology industry. Portfolio management may consider information about Environmental, Social and Governance (ESG) issues in its fundamental research process and when making investment decisions. Securities lending. The fund may lend securities (up to one-third of total assets) to approved institutions, such as registered broker-dealers, banks and pooled investment vehicles.
|Asset Type||% Of Allocation|
|Total Net Assets||1.22 B|
|Criteria||3 Years||5 Years||10 Years|
|Minimum Initial IRA||$500|
|Timeframe||Average Annual Current Performance Monthly As Of 08/31/2021||Average Annual Current Performance Quarterly As Of 06/30/2021||Avg Annual Current Performance Monthly As Of 08/31/2021||Avg Annual Current Performance Quarterly As Of 06/30/2021|
|Life Of Fund||
Join the Action Alerts PLUS Community today!
'Redwire offers a diversified portfolio of space components that are well-positioned to capture emerging trends,' Jefferies says.
Uncertain fiscal and monetary policies could prompt a stock correction, the noted bull Phil Orlando says.
Sanofi says its COVID vaccine candidate has positive test results, but the company is ready to drop its development because of the Moderna and Pfizer vaccines.
Roku's 'unique position as a neutral player with a large installed base should allow it to continue gaining market share,' Bank of America says.
Aurora Cannabis had a tough quarter, but Cowen analysts still expect strong growth margins in 2022.
Identity-management provider Okta was upgraded to overweight at Morgan Stanley amid rebounding demand.
Failure to lift the $28.4 trillion debt ceiling this week could put the U.S. at risk of default as early as October 18, Treasury Secretary Janet Yellen told Senate lawmakers Tuesday.
AMAT's valuation 'is still very reasonable,' New Street says. 'But we don’t see a near-term catalyst for a rerating.'